Miguel Angel Gomez Lim

Dr. Miguel Angel Gomez Lim


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2006 in Transgenic Research
Verified
Journal Article
Closed access
PDF file
OGOctavio Guerrero-Andrade
Octavio Guerrero-Andrade
ELElizabeth Loza-Rubio
Elizabeth Loza-Rubio
TOTeresa Olivera-Flores
Teresa Olivera-Flores
TFTamás Fehérvári-Bone
Tamás Fehérvári-Bone
MLMiguel Angel Gomez Lim
Miguel Angel Gomez Lim

1 October 2014 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
NCNancy Coconi-Linares
Nancy Coconi-Linares
DMDenis Magaña-Ortíz
Denis Magaña-Ortíz
DGDoralinda A. Guzmán-Ortiz
Doralinda A. Guzmán-Ortiz
FFFrancisco Fernández
Francisco Fernández
Achim Max LoskeAchim Max Loske
Achim Max Loske
MLMiguel Angel Gomez Lim
Miguel Angel Gomez Lim

1 June 2014 in Physics of Life Reviews
Verified
Journal Article
Closed access
ARAna Leonor Rivera
Ana Leonor Rivera
DMDenis Magaña-Ortíz
Denis Magaña-Ortíz
MLMiguel Angel Gomez Lim
Miguel Angel Gomez Lim
FFFrancisco Fernández
Francisco Fernández
Achim Max LoskeAchim Max Loske
Achim Max Loske

6 January 2009 in Virology Journal
Verified
Journal Article
Open access
PDF file
GRGeorgina Paz de la Rosa
Georgina Paz de la Rosa
AMAlberto Monroy-García
Alberto Monroy-García
AMAlberto Monroy-García
Alberto Monroy-García
CRCristina Gehibie Reynaga
Cristina Gehibie Reynaga
JHJorge Hernández-Montes
Jorge Hernández-Montes
MLMiguel Angel Gomez Lim
Miguel Angel Gomez Lim
Background: Even though two prophylactic vaccines against HPV are currently licensed, infections by the virus continue to be a major health problem mainly in developing countries. The cost of the vaccines limits wide-scale application in poor countries. A promising strategy for producing affordable and efficient vaccines involves the expression of recombinant immunogens in plants. Several HPV genes have been expressed in plants, including L1, which can self-assemble into virus-like particles. A plant-based, dual prophylactic/therapeutic vaccine remains an attractive possibility.Results: We sought to express in tomato plants chimeric HPV 16 VLPs containing L1 fused to a string of epitopes from HPV 16 E6 and E7 proteins. The L1 employed had been modified to eliminate a strong inhibitory region at the 5' end of the molecule to increase expression levels. Several tomato lines were obtained expressing either L1 alone or L1-E6/E7 from 0.05% to 0.1% of total soluble protein. Stable integration of the transgenes was verified by Southern blot. Northern and western blot revealed successful expression of the transgenes at the mRNA and protein level. The chimeric VLPs were able to assemble adequately in tomato cells. Intraperitoneal administration in mice was able to elicit both neutralizing antibodies against the viral particle and cytotoxic T-lymphocytes activity against the epitopes.Conclusion: In this work, we report for the first time the expression in plants of a chimeric particle containing the HPV 16 L1 sequence and a string of T-cell epitopes from HPV 16 E6 and E7 fused to the C-terminus. The particles were able to induce a significant antibody and cytotoxic T-lymphocytes response. Experimentsin vivoare in progress to determine whether the chimeric particles are able to induce regression of disease and resolution of viral infection in mice. Chimeric particles of the type described in this work may potentially be the basis for developing prophylactic/therapeutic vaccines. The fact that they are produced in plants, may lower production costs considerably.

1 September 2004 in In Vitro Cellular & Developmental Biology - Plant
Verified
Journal Article
Closed access
PDF file
MLMiguel Angel Gomez Lim
Miguel Angel Gomez Lim
RLRichard E. Litz
Richard E. Litz
Genetic transformation provides the means for modifying single horticultural traits in perennial plant cultivars without altering their phenotype. This capability is particularly valuable for perennial plants and tree species in which development of new cultivars is often hampered by their long generation time, high levels of heterozygosity, nucellar embryony, etc. Most of these conditions apply to many tropical and subtropical fruit crops. Targeting specific gene traits is predicated upon the ability to regenerate elite selections of what are generally trees from cell and tissue cultures. The integrity of the clone would thereby remain unchanged except for the altered trait. This review provides an overview of the genetic transformation of perennial tropical and subtropical fruit crops, i.e., citrus (Citrus spp.), banana and plantain (Musa groups AAA, AAB, ABB, etc.), mango (Mangifera indica L.), pineapple (Ananas comosus L.), avocado (Persea americana Mill.), passion fruit (Passiflora edulis L.), longan (Dimocarpus longan Lour.), and litchi (Litchi chinensis Sonn.).

1 September 2015 in Journal of Biotechnology
Verified
Journal Article
Closed access
NCNancy Coconi-Linares
Nancy Coconi-Linares
EOElizabeth Ortiz-Vázquez
Elizabeth Ortiz-Vázquez
FFFrancisco Fernández
Francisco Fernández
Achim Max LoskeAchim Max Loske
Achim Max Loske
MLMiguel Angel Gomez Lim
Miguel Angel Gomez Lim